Skip to main content
Steve Bogen, MD, Pathology, Boston, MA

Steve A Bogen MD

Anatomic Pathology, Clinical Pathology


Director, Clinical Chemistry Laboratory

Join to view full profile
  • 800 Washington StBox 115Boston, MA 02111

  • Phone+1 617-636-5422

  • Fax+1 617-636-7128

Dr. Bogen is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1986 - 1991
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1986

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1987 - 2027
  • Clinical Pathology
    American Board of Pathology Clinical Pathology

Publications & Presentations

PubMed

Press Mentions

  • Boston Cell Standards: Calibration Transforms Accuracy in HER2-Low Breast Cancer Testing
    Boston Cell Standards: Calibration Transforms Accuracy in HER2-Low Breast Cancer TestingNovember 19th, 2025
  • Boston Cell Standards Wins FDA $510K Clearance for Anatomic Pathology Controls
    Boston Cell Standards Wins FDA $510K Clearance for Anatomic Pathology ControlsOctober 12th, 2022
  • Boston Cell Standards Moves to Final Phase of FDA Program for Cancer Diagnostic Standards
    Boston Cell Standards Moves to Final Phase of FDA Program for Cancer Diagnostic StandardsApril 28th, 2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: